Skip to main content

Want a detailed portfolio tracker?

Lexeo Therapeutics (LXEO) P/E (2024 - 2026)

Lexeo Therapeutics (LXEO) P/E from Jan 2, 2024 to Jul 21, 2026. The TTM Lexeo Therapeutics (LXEO) P/E is -1.87. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lexeo Therapeutics (LXEO)

YearP/EChange
2026-1.87-39.69%
2025-3.10+40.12%
2024-2.21N/A

Comparison Lexeo Therapeutics (LXEO) P/E with competitors

Lexeo Therapeutics (LXEO) P/E is -1.87.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.23%
ENLVEnlivex Ltd0.07-104.00%
FGENFibroGen Inc0.24-112.85%
CHRSCoherus Biosciences Inc0.85-145.43%
FBIOFortress Biotech Inc0.95-150.81%
ORMPOramed Pharmaceuticals Inc1.50-180.47%
AGENAgenus Inc3.01-261.13%
INVAInnoviva Inc3.15-268.86%
VXRTVaxart Inc3.55-290.05%
CRMDCorMedix Inc3.63-294.26%
CVACCureVac N.V.4.45-338.02%
GLPGGalapagos NV4.86-360.14%
SRPTSarepta Therapeutics Inc4.88-361.38%
ABEOAbeona Therapeutics Inc5.39-388.44%
ABUSArbutus Biopharma Corp5.60-399.58%
ZVRAZevra Therapeutics Inc5.89-415.20%
SPROSpero Therapeutics Inc6.23-433.46%
CGENCompugen Ltd6.31-438.04%
RIGLRigel Pharmaceuticals6.87-467.92%
SLXNSilexion Therapeutics Corp7.30-490.62%
OMEROmeros Corporation9.26-595.70%
AUPHAurinia Pharmaceuticals Inc9.58-613.17%
PLXProtalix BioTherapeutics Inc10.89-683.09%
ACADAcadia Pharmaceuticals Inc11.73-727.93%
TBPHTheravance Biopharma Inc12.26-756.50%
ADMAAdma Biologics Inc12.42-764.85%
HRMYHarmony Biosciences Holdings Inc13.82-839.92%
SABSSAB Biotherapeutics Inc14.14-856.84%
NAGENiagen Bioscience Inc14.82-893.35%
INCYIncyte Corp15.82-947.12%
REGNRegeneron Pharmaceuticals Inc15.86-948.95%
PBYIPuma Biotechnology Inc17.32-1027.07%
CPRXCatalyst Pharmaceuticals Inc17.44-1033.68%
EXELExelixis Inc17.54-1038.97%
TGTXTG Therapeutics Inc18.97-1115.42%
MDXGMimedx Group Inc20.55-1200.36%
XOMAXOMA Royalty Corp22.87-1324.72%
ARGXArgen X SE24.30-1400.93%
CTMXCytomX Therapeutics Inc24.82-1428.93%
XOMAOXOMA Royalty Corp25.34-1456.97%
HALOHalozyme Therapeutics Inc25.62-1471.91%
XOMAPXOMA Royalty Corp25.67-1474.39%
VRTXVertex Pharmaceuticals Inc27.99-1598.85%
RPRXRoyalty Pharma plc - Class A28.69-1635.94%
SLNOSoleno Therapeutics Inc29.02-1653.49%
ASNDAscendis Pharma A/S30.09-1710.79%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2129.83%
APLSApellis Pharmaceuticals Inc39.02-2189.21%
BMRNBiomarin Pharmaceutical Inc42.21-2360.04%
KRYSKrystal Biotech Inc45.34-2527.71%
ONCBeiGene Ltd69.54-3823.23%
PHARPharming Group N.V.75.03-4116.91%
TECHBio-Techne Corp101.96-5558.90%
VCELVericel Corp109.92-5985.24%
ALNYAlnylam Pharmaceuticals Inc117.96-6415.91%
GMABGenmab140.29-7611.24%
TLXTelix Pharmaceuticals Ltd162.15-8781.74%
CORTCorcept Therapeutics Inc212.86-11496.50%